TOTomoyuki Ohara

Tomoyuki Ohara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tomoyuki Ohara has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Mao Shibata

    Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    15 shared publications
  • Jun Hata

    Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    12 shared publications
  • Toshiharu Ninomiya

    Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    12 shared publications
  • Takanari Kitazono

    Department of Medicine and Clinical Science, Graduate School of Medical Sciences Kyushu university Fukuoka Japan

    9 shared publications
  • Yoshihiko Furuta

    Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    9 shared publications
  • Takanori Honda

    Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    8 shared publications

Latest Publications

  • Impact of antithyroid drug duration on radioactive iodine therapy efficacy in Graves’ disease in Japan: a propensity score-matched analysis using thyroid weight-based outcomes

    by Seigo Tachibana, Tomoyuki Ohara, Yuji Nagayama, Takashi Fukuda, Daisuke Tatsushima, Yusuke Mori, Hisakazu Shindo, Hiroshi Takahashi, Shinya Sato, Hiroyuki Yamashita

    Radioactive iodine therapy (RAIT) is an established treatment option for Graves’ disease (GD). In Japan, antithyroid drugs (ATDs) are typically first-line therapy, with RAIT or thyroidectomy reserv...

  • Open Access

    Short-term and long-term reversion rates to normal cognition and their contributing factors among individuals with mild cognitive impairment in a Japanese community: the Hisayama study

    by Kaishi Takabatake, Tomoyuki Ohara, Toshifumi Minohara, Taro Nakazawa, Emi Oishi, Yoshihiko Furuta, Satoko Sakata, Mao Shibata, Tomohiro Nakao, Toshiharu Ninomiya

    Background: Individuals with mild cognitive impairment (MCI) have a high risk of developing dementia, but some remain cognitively stable or even revert to normal cognition (NC), with reported reversion rates varying widely and inconsistent findings regarding contributing factors. The purposes of this study were to investigate the reversion rate from MCI to NC in a community-dwelling older Japanese population and to identify factors associated with reversion. Methods: Three community-based surveys of cognitive function were conducted in the town of Hisayama among residents aged 65 years or older in 2012–2013, 2017–2018, and 2022–2023 (participation rate > 92% for each time range). The 5-year reversion rate from MCI to NC was examined using a pooled cohort, combining two cohorts from the 2012–2013 to the 2017–2018 survey and from the 2017–2018 to the 2022–2023 survey. A logistic regression analysis with generalized estimating equations was used to identify factors associated with reversion to NC based on the pooled cohort data. To evaluate the 10-year reversion rate of MCI, moreover, 171 participants diagnosed with MCI in the 2012–2013 survey were followed for 10 years. Results: The 5-year reversion rate from MCI to NC in the pooled cohort was 31.3% (95% confidence interval, 26.9%–36.2%). Younger age, lower systolic blood pressure, absence of diabetes mellitus, absence of instrumental activities of daily living impairment, higher handgrip strength, higher Mini-Mental State Examination (MMSE) score, larger total brain volume, and smaller cerebral white matter lesion volume were significantly associated with reversion to NC. Meanwhile, the 10-year reversion rate from MCI to NC was 18.1% (13.1%–24.6%). Of individuals who reverted from MCI to NC in the 2017–2018 survey, 48.1% (35.0%–61.5%) maintained NC five years later, 32.7% (21.4%–46.4%) returned to MCI, and 5.8% (1.9%–16.4%) progressed to dementia. Conclusions: In a Japanese community-dwelling older population with MCI, approximately 30% and 18% reverted to NC for 5 years and 10 years, respectively. The prevention and proper management of lifestyle-related diseases and promotion of healthy lifestyle behaviors may play a crucial role in facilitating reversion to NC in older individuals with MCI.


  • Open Access

    Thirty-seven-year trends in the prevalence, incidence, and prognosis of dementia in a Japanese community: the Hisayama study

    by Tomoyuki Ohara, Toshifumi Minohara, Taro Nakazawa, Emi Oishi, Yoshihiko Furuta, Satoko Sakata, Takanori Honda, Mao Shibata, Jun Hata, Tomohiro Nakao, et al.

    Background: Few population-based studies have investigated how the prevalence, incidence, and survival rate of dementia have changed since the 2010s in Asian communities. We investigated this issue using 37 years of epidemiological data in a Japanese community. Methods: Seven cross-sectional surveys of dementia were conducted among residents aged ≥ 65 years in a Japanese community in 1985, 1992, 1998, 2005, 2012, 2017, and 2022. We also established three cohorts in the residents aged ≥ 65 years without dementia in 1988 ( n = 803), 2002 ( n = 1,231), and 2012 ( n = 1,519), each of which was followed for 10 years. Trends in the prevalence of dementia were tested using a logistic regression model. The age- and sex-adjusted incidence of dementia and survival rate after dementia onset were compared across cohorts using a Cox proportional hazards model. Results: The crude prevalence of dementia significantly increased from 1985 to 2012 (6.7% in 1985, 5.7% in 1992, 7.1% in 1998, 12.5% in 2005, and 17.9% in 2012, p for trend < 0.01), but then decreased significantly from 2012 to 2022 (15.8% in 2017 and 12.1% in 2022; p for trend < 0.01). A similar trend was observed after adjusting for age and sex. Moreover, the age- and sex-adjusted incidence of dementia increased significantly from the 1988 to the 2002 cohort (adjusted hazard ratio [aHR] 1.68, 95% confidence intervals [CI] = 1.38–2.06), but decreased significantly from the 2002 to the 2012 cohort (aHR = 0.60, 95% CI = 0.51–0.70). The age- and sex-adjusted 5-year survival rate after dementia onset increased significantly from the 1988 to the 2002 cohort (47.3% to 65.2%; p < 0.01), while no significant change was observed from the 2002 to the 2012 cohort (65.2% to 58.9%; p = 0.42). Conclusions: Decreasing trends in the prevalence and incidence of dementia were observed since 2012 in a Japanese community. The decline in the incidence of dementia may be due to the prevention and improved management of lifestyle-related diseases, such as hypertension and diabetes, as well as increased awareness and promotion of healthy lifestyle behaviors.


  • Open Access

    Serum ergothioneine and risk of dementia in a general older Japanese population: the Hisayama Study

    by Xiangyin Meng, Tomoyuki Ohara, Kentaro Nishioka, Mao Shibata, Makoto Katsube, Norifumi Tateishi, Yumi Nakamura, Emi Oishi, Satoko Sakata, Yoshihiko Furuta, et al.

    Aim: To investigate the association between serum ergothioneine and risk of developing dementia and its subtypes in a community‐dwelling older population. Methods: In this prospective longitudinal analysis of participants enrolled in the Hisayama Study, 1344 Japanese community‐residents aged 65 years and over without dementia at baseline were followed prospectively for a median of 11.2 years (2012–2023). Serum ergothioneine levels were quantified using liquid chromatography–mass spectrometry and divided into quartiles. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and their 95% confidence intervals for the association between serum ergothioneine levels and the risk of dementia subtypes. Results: During the follow‐up, 273 participants developed all‐cause dementia. Among them, 201 had Alzheimer's disease (AD) and 72 had non‐Alzheimer's disease (non‐AD) dementia. The age‐ and sex‐adjusted HRs for all‐cause dementia, AD, and non‐AD dementia decreased progressively across increasing quartiles of serum ergothioneine (all P for trend P for trend <0.05). In subgroup analyses stratified by daily vegetable intake, higher serum ergothioneine levels were consistently associated with lower dementia risk, irrespective of vegetable consumption. Conclusions: Our findings showed that higher serum ergothioneine levels were associated with a lower risk of developing all‐cause dementia, AD, and non‐AD dementia in an older Japanese population. Since ergothioneine cannot be synthesized in the human body, a diet rich in ergothioneine may be beneficial in reducing the risk of dementia.


  • Open Access

    Association of impaired olfactory identification with prevalent mild cognitive impairment and regional brain atrophy: the Hisayama Study

    by Toshifumi Minohara, Tomoyuki Ohara, Taro Nakazawa, Naoki Hirabayashi, Yoshihiko Furuta, Mao Shibata, Jun Hata, Takanari Kitazono, Tomohiro Nakao, Toshiharu Ninomiya

    Aim: To investigate the association of olfactory identification ability with both the prevalence of mild cognitive impairment (MCI) and regional brain atrophy in a community‐dwelling older population.Methods: A total of 1293 participants without dementia aged 65 years or older underwent a Japanese version of the 4‐Item Pocket Smell Test, an assessment of cognitive function, and brain magnetic resonance imaging scanning in 2017–2018. Regional gray matter volumes (GMVs) and white matter lesions volume (WMLV) were estimated using FreeSurfer software. The association of impaired olfactory identification with the presence of MCI and regional GMVs or WMLV was estimated by logistic regression analysis and ANCOVA, respectively. We also assessed the association between impaired olfactory identification and GMVs without regions of interest, using a voxel‐based morphometry (VBM) analysis.Results: Participants with impaired olfactory identification had a significantly higher likelihood of MCI than those without (odds ratio, 1.99 [95% confidence interval, 1.36–2.91]). In the FreeSurfer analysis, participants with impaired olfactory identification had significantly lower GMVs in the entorhinal cortex, inferior temporal gyrus, amygdala, thalamus, hippocampus, and cingulate gyrus, and higher WMLV than those without. The VBM analysis also showed that impaired olfactory identification was significantly associated with lower volume of the left entorhinal cortex, left amygdala, left hippocampus, bilateral thalami, and bilateral subcallosal areas.Conclusion: Our findings suggest that cognitive function and brain changes may need to be evaluated in older individuals with impaired olfactory identification, which may reflect the extent of neurodegeneration, WMLV, and subsequent cognitive impairment.


  • Open Access

    37‐year secular trends in prevalence, incidence, and survival rate of dementia in a Japanese community: the Hisayama Study

    by Tomoyuki Ohara, Toshifumi Minohara, Taro Nakazawa, Jun Hata, Mao Shibata, Toshiharu Ninomiya

    Background: Few population‐based prospective studies have investigated whether the prevalence, incidence, and survival rate of dementia in a community have changed since the 2010s.Method: Seven cross‐sectional surveys of dementia were conducted among residents of a Japanese community, aged ≥65 years, in 1985, 1992, 1998, 2005, 2012, 2017, and 2022. We also established three cohorts consisting of the residents of this age group without dementia in 1988 (n = 803), 2002 (n = 1,231), and 2012 (n = 1,521) and each was followed for 10 years. Trends in the prevalence of dementia were tested by using the logistic regression model. The age‐ and sex‐adjusted incidence and survival rate of dementia were compared between cohorts using the Cox proportional hazards model.Result: The crude prevalence of dementia increased with time from 1985 to 2012 (6.7% in 1985, 5.7% in 1992, 7.1% in 1998, 12.5% in 2005, and 17.9% in 2012, p for trend <0.01), while the crude prevalence of dementia decreased with time from 2012 to 2022 (17.9% in 2012, 15.6% in 2017, and 11.9% in 2022, p for trend <0.01). These secular changes did not change even after standardizing by age. The age‐ and sex‐adjusted incidence of dementia significantly increased from the 1988 cohort to the 2002 cohort (adjusted hazard ratio [aHR] = 1.7, 95% confidence intervals [CI] = 1.4‐2.1). However, the age‐ and sex‐adjusted incidence of dementia significantly decreased from the 2002 cohort to 2012 cohort (aHR = 0.6, 95% CI = 0.5‐0.7). The age‐ and sex‐adjusted 5‐year survival rate of dementia significantly improved from the 1988 cohort to the 2002 cohort (47.3% to 65.2%, p<0.01), while no secular change was observed from the 2002 cohort to the 2012 cohort (65.2% to 58.3%, p = 0.39).Conclusion: The decreasing trends in the prevalence and incidence of dementia were observed since 2012 in the Japanese older population. The decline in the incidence of dementia may be due to prevention of lifestyle‐related diseases, such as hypertension and diabetes, and improvement of proper management of the disease, as well as awareness and promotion of healthy lifestyle behaviors.


  • Open Access

    Plasma biomarkers for predicting the development of dementia in a community‐dwelling older Japanese population

    by Tomoyuki Ohara, Harutsugu Tatebe, Jun Hata, Takanori Honda, Mao Shibata, Sayo Matsuura, Tatsuya Mikami, Tetsuya Maeda, Kenjiro Ono, Masaru Mimura, et al.

    Aim: To assess the association between plasma amyloid β (Aβ) 42/40, phosphorylated tau (p‐τ)181, glial fibrillary acidic protein (GFAP), or neurofilament light chain (NfL) and the risk of dementia and to determine whether these plasma biomarkers could improve the ability to predict incident dementia in a general older population.Methods: A total of 1346 Japanese community‐dwelling individuals aged ≥65 years without dementia were followed prospectively for 5.0 years. Plasma biomarkers were quantified using a Simoa HD‐X analyzer. A Cox proportional hazards model was used to estimate the hazard ratios of each plasma biomarker level for the risk of dementia.Results: During the follow‐up, 151 participants developed dementia, of whom 108 had Alzheimer disease (AD) and 43 non–Alzheimer dementia (non‐AD). Lower plasma Aβ42/40 levels and higher plasma p‐τ181 levels were significantly associated with developing AD but not non‐AD, whereas significant associations were observed between higher plasma levels of GFAP and NfL and risk of both AD and non‐AD (all P for trend <0.05). In addition, adding these four plasma biomarkers into a model consisting of the total score of the dementia risk model significantly improved the predictive ability for incident dementia.Conclusion: Our findings suggest that plasma Aβ42/40 and p‐τ181 are specific markers of AD, and plasma GFAP and NfL are potential biomarkers for all‐cause dementia in the general Japanese older population. In addition, the measurement of these plasma biomarkers may be a useful and relatively low‐invasive procedure for identifying individuals at high risk for developing dementia in clinical practice.


  • Open Access

    Association of white matter lesions and brain atrophy with the development of dementia in a community: the Hisayama Study

    by Taro Nakazawa, Tomoyuki Ohara, Naoki Hirabayashi, Yoshihiko Furuta, Jun Hata, Mao Shibata, Takanori Honda, Takanari Kitazono, Tomohiro Nakao, Toshiharu Ninomiya

    Aim: To investigate the association of white matter lesions volume (WMLV) levels with dementia risk and the association between dementia risk and the combined measures of WMLV and either total brain atrophy or dementia‐related gray matter atrophy in a general older population.Methods: One thousand one hundred fifty‐eight Japanese dementia‐free community‐residents aged ≥65 years who underwent brain magnetic resonance imaging were followed for 5.0 years. WMLV were segmented using the Lesion Segmentation Toolbox. Total brain volume (TBV) and regional gray matter volume were estimated by voxel‐based morphometry. The WMLV‐to‐intracranial brain volume ratio (WMLV/ICV) was calculated, and its association with dementia risk was estimated using Cox proportional hazard models. Total brain atrophy, defined as the TBV‐to‐ICV ratio (TBV/ICV), and dementia‐related regional brain atrophy defined based on our previous report were calculated. The association between dementia risk and the combined measures of WMLV/ICV and either total brain atrophy or the number of atrophied regions was also tested.Results: During the follow‐up, 113 participants developed dementia. The risks of dementia increased significantly with higher WMLV/ICV levels. In addition, dementia risk increased additively both in participants with higher WMLV/ICV levels and lower TBV/ICV levels and in those with higher WMLV/ICV levels and a higher number of dementia‐related brain regional atrophy.Conclusion: The risk of dementia increased significantly with higher WMLV/ICV levels. An additive increment in dementia risk was observed with higher WMLV/ICV levels and lower TBV/ICV levels or a higher number of dementia‐related brain regional atrophy, suggesting the importance of prevention or control of cardiovascular risk factors.


  • Open Access

    Association of serum s-adenosylmethionine, s-adenosylhomocysteine, and their ratio with the risk of dementia and death in a community

    by Akane Mihara, Tomoyuki Ohara, Jun Hata, Sanmei Chen, Takanori Honda, Sonam Tamrakar, Akiko Isa, Dongmei Wang, Kuniyoshi Shimizu, Yoshinori Katakura, et al.

    We examined the association of serum s-adenosylmethionine (SAM), s-adenosylhomocysteine (SAH) (methionine metabolites), and their ratio on the risk of dementia and death in a community-dwelling population of older Japanese individuals. 1371 residents of Hisayama, Japan, aged 65 years or older and without dementia, were followed for a median of 10.2 years (2007–2017). We divided serum SAM, SAH, and SAM/SAH ratio into quartiles. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and their 95% confidence intervals (CIs) of serum SAM, SAH, and SAM/SAH ratio levels on the risk of a composite outcome of all-cause dementia or death, and each outcome. During the follow-up, 635 participants developed all-cause dementia and/or died, of which 379 participants developed dementia and 394 deaths occurred. The multivariable-adjusted HRs of the composite outcome decreased significantly with increasing serum SAM levels (Pfor trend = 0.01), while they increased significantly with higher serum SAH levels (Pfor trend = 0.03). Higher serum SAM/SAH ratio levels were significantly associated with a lower risk of the composite outcome (Pfor trend = 0.002), as well as with lower risk of each outcome. Our findings suggest that the balance of methionine metabolites may closely associate with the risk of dementia and death.


  • Open Access

    Association of Inner Retinal Thickness with Prevalent Dementia and Brain Atrophy in a General Older Population

    by Emi Ueda, Naoki Hirabayashi, Tomoyuki Ohara, Jun Hata, Takanori Honda, Kohta Fujiwara, Yoshihiko Furuta, Mao Shibata, Sawako Hashimoto, Shun Nakamura, et al.